In contrast, MYO1B depletion in the same MNA+ NB cells strongly inhibited cell invasiveness (Fig. 4, D to F) and markedly reduced gelatin degradation capacity by NB cells (Fig. 4G), suggesting that MYO1B might confer metastatic capacity. The gene discussed is MYO1B; the disease is neuroblastoma.